US Immigration Ban Affects Scientists

President Trump signed a sweeping executive order last week, temporarily banning refugees and some visitors from seven countries. The move is already affecting individual scientists and international research.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

TWITTER, @JUSTINQTAYLORInternational collaboration is a bedrock of modern science, so President Donald Trump’s signing last week of an executive order that barred refugees and some visitors from seven countries from entering the U.S. garnered a strong response from the communities that rely on open borders to conduct research.

“Our borders are a creation of human beings, but dust, pollution, wind, heat, ocean energies and flows—they don’t pay any attention to international boundaries. These things have an enormous impact on us and we have to study these things with a global perspective,” Matthew Scott, president of the Carnegie Institution, told The Washington Post. “Any infringement, especially an entirely unnecessary one, on the free flow of brilliant people . . . is shooting ourselves in the foot.”

And the so-called immigration ban is already harming working scientists, Nature reports. Luca Freschi, an Italian microbial geneticist described how his plans to conduct research at Harvard were put on hold, since the ban would prevent his Iranian wife from joining him abroad. Samira Samimi, an Iranian glaciologist, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies